|Articles|November 18, 2009

TAKE Supply Chain Releases Software Solution for Supplier Collaboration

Austin, Texas-November 18, 2009

TAKE Supply Chain (formerly ClearOrbit) has released Xtended Process Control (X.PC) 5.7d, which is an upgrade to its software that was developed to accelerate and streamline supplier collaboration and extend lean processes by connecting manufacturers and distributors with supply chain partners worldwide to procure goods and services.

TAKE's X.PC 5.7d new features and modules include:
* Web labels, which enable the printing of package tracking numbers (PTN) and advance shipment notice (ASN) labels without a dedicated label printer; * A quick search toolbar, which finds and jumps to POs, invoices, shipments, or quality documents by displaying a list of search results;
* An Engineering Quality Collaboration module to manage the workflow of supplier deviation requests and corrective actions;
* An expanded Accounts Payable module that allows suppliers to create credits as well as invoices, print Invoice PDFs, and view invoice holds; and
* Additional enhancements to existing purchase order and ASN functionality.

“As many corporations turn to collaboration to gain supply chain efficiencies, the speed at which a solution can be used to on-board external entities becomes an important factor,” said Dusty Knight, TAKE Supply Chain vice president of professional services.

 


Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.